Evidence map›Paper›PMID 29891792›Full record

ArticleCancers2018

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Kevin Washetine, Mehdi Kara-Borni, Simon Heeke, Christelle Bonnetaud, Jean-Marc Félix, Lydia Ribeyre, Coraline Bence, Marius Ilié, Olivier Bordone, Marine Pedro and 14 more

Abstract read
In one paragraph

Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kevin WashetineHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. washetine.k@chu-nice.fr.
Mehdi Kara-BorniHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. mehdi.kara-borni@etu.unice.fr.ORCID 0000-0002-7697-5897
Simon HeekeTeam 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Université Côte d'Azur, CHU de Nice, 06107 Nice CEDEX 2, France. heeke.s@chu-nice.fr.
Christelle BonnetaudHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. bonnetaud.c@chu-nice.fr.
Jean-Marc FélixHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. felix.jm@chu-nice.fr.
Lydia RibeyreHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. ribeyre.l@chu-nice.fr.
Coraline BenceTeam 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Université Côte d'Azur, CHU de Nice, 06107 Nice CEDEX 2, France. bence.c@chu-nice.fr.
Marius IliéHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. ilie.m@chu-nice.fr.ORCID 0000-0002-2014-1236
Olivier BordoneHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. bordone.o@chu-nice.fr.
Marine PedroHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. pedro.m@chu-nice.fr.
Priscilla MaitreHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. Priscilla.maitre@gmail.com.
Virginie TangaHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. tanga.v@chu-nice.fr.
Emmanuelle GormallyUniversité de Lyon, UMRS 449; Laboratoire de Biologie générale, Université Catholique de Lyon; Reproduction et développement comparé, EPHE, 69002 Lyon, France. egormally@univ-catholyon.fr.
Pascal MossuzBiobank of Grenoble (BB-0033-00069), 38043 Grenoble, France. PMossuz@chu-grenoble.fr.
Philippe LorimierBiobank of Grenoble (BB-0033-00069), 38043 Grenoble, France. PLorimier@chu-grenoble.fr.
Charles Hugo MarquetteTeam 4, Institute of Research on Cancer and Aging of Nice (IRCAN), Inserm U1081, CNRS UMR7284, Université Côte d'Azur, CHU de Nice, 06107 Nice CEDEX 2, France. marquette.c@chu-nice.fr.
Jérôme MourouxDepartment of Thoracic Surgery, Université Côte d'Azur, CHU de Nice, University Hospital Federation OncoAge, 06001 Nice CEDEX 1, France. mouroux.j@chu-nice.fr.
Charlotte CohenDepartment of Thoracic Surgery, Université Côte d'Azur, CHU de Nice, University Hospital Federation OncoAge, 06001 Nice CEDEX 1, France. cohen.c@chu-nice.fr.
Sandra LassalleHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. lassalle.s@chu-nice.fr.
Elodie Long-MiraHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. long-mira.e@chu-nice.fr.
Bruno ClémentINSERM INRA, NuMeCan, Rennes University, CRB Santé, CHU Rennes, 35000 Rennes, France. bruno.clement@inserm.fr.
Georges DagherINSERM, 75654 Paris, France. georges.dagher@inserm.fr.
Véronique HofmanHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. hofman.v@chu-nice.fr.
Paul HofmanHospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, CHU de Nice, 06001 Nice CEDEX 1, France. hofman.p@chu-nice.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Collected specimens for research purposes may or may not be made available depending on their scarcity and/or on the project needs. Their protection against degradation or in the event of an incident is pivotal. Duplication and storage on a different site is the best way to assure their sustainability. The conservation of samples at room temperature (RT) by duplication can facilitate their protection. We describe a security system for the collection of non-small cell lung cancers (NSCLC) stored in the biobank of the Nice Hospital Center, France, by duplication and conservation of lyophilized (dried), encapsulated DNA kept at RT. Therefore, three frozen tissue collections from non-smoking, early stage and sarcomatoid carcinoma NSCLC patients were selected for this study. DNA was extracted, lyophilized and encapsulated at RT under anoxic conditions using the DNAshell technology. In total, 1974 samples from 987 patients were encapsulated. Six and two capsules from each sample were stored in the biobanks of the Nice and Grenoble (France) Hospitals, respectively. In conclusion, DNA maintained at RT allows for the conservation, duplication and durability of collections of interest stored in biobanks. This is a low-cost and safe technology that requires a limited amount of space and has a low environmental impact.

Indexed as

biobankDNAgenomicinternational networkslung cancerpersonalized medicineresearch projectssecuritysustainabilitytumor tissues

Identifiers

PMID29891792
PMCPMC6025404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.